Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

46.08
+0.45000.99%
Post-market: 45.16-0.9200-2.00%16:55 EDT
Volume:852.48K
Turnover:39.13M
Market Cap:3.52B
PE:61.44
High:46.34
Open:45.64
Low:44.62
Close:45.63
52wk High:49.12
52wk Low:18.26
Shares:76.29M
Float Shares:35.24M
Volume Ratio:1.20
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7500
EPS(LYR):0.7500
ROE:11.73%
ROA:7.18%
PB:6.19
PE(LYR):61.44

Loading ...

Kiniksa Pharmaceuticals Q4 Net Income USD 14.199 Million

THOMSON REUTERS
·
Feb 24

Kiniksa Pharmaceuticals Q4 Pretax Profit USD 23.269 Million

THOMSON REUTERS
·
Feb 24

Kiniksa Pharmaceuticals International PLC expected to post earnings of 37 cents a share - Earnings Preview

Reuters
·
Feb 20

Kiniksa Pharmaceuticals International plc published an update to their financial calendar

Reuters
·
Feb 20

Canaccord Genuity Initiates Coverage on Kiniksa Pharmaceuticals International With Buy Rating, $62 Price Target

MT Newswires Live
·
Feb 19

Kiniksa initiated with a Buy at Canaccord

TIPRANKS
·
Feb 19

Director Barry D. Quart Reports Disposal of Kiniksa Pharmaceuticals International plc Common Shares

Reuters
·
Feb 13

Director Barry D. Quart Reports Disposal of Common Shares in Kiniksa Pharmaceuticals International plc

Reuters
·
Feb 05

Kiniksa Pharmaceuticals Appoints Ross Moat COO and Eben Tessari Chief Strategy Officer

Reuters
·
Jan 15

Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush

Dow Jones
·
Jan 13

Wedbush Adjusts Price Target on Kiniksa Pharmaceuticals International to $50 From $48, Maintains Outperform Rating

MT Newswires Live
·
Jan 13

Kiniksa Pharmaceuticals Showcases Pipeline Progress and Cardiovascular Focus in New Corporate Presentation

Reuters
·
Jan 12

Kiniksa Projects Continued Annual Cash Flow Positivity for 2026

Reuters
·
Jan 12

Kiniksa Pharmaceuticals International Plc - Kpl-387 Phase 2 Data Expected in 2H 2026

THOMSON REUTERS
·
Jan 12

Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares

Reuters
·
Jan 10

How Investors Are Reacting To Kiniksa (KNSA) KPL-387 Progress And A Fresh Analyst Buy Rating

Simply Wall St.
·
Dec 24, 2025

Director Barry D. Quart Reports Disposal of Kiniksa Pharmaceuticals International plc Common Shares

Reuters
·
Dec 18, 2025

US High Growth Tech Stocks to Watch

Simply Wall St.
·
Dec 16, 2025

Kiniksa COO Eben Tessari Reports Disposal of Common Shares

Reuters
·
Dec 02, 2025

Kiniksa CFO Mark Ragosa Reports Disposal of Common Shares

Reuters
·
Nov 15, 2025